The present application discloses novel piperazinyl-alkyl-benzoimidazol-2-one derivatives useful as monoamine neurotransmitter re-uptake inhibitors. In other aspects the invention discloses the use of these compounds in a method for therapy, and pharmaceutical compositions comprising the compounds of the invention.
本申请披露了一种新颖的
哌嗪基-烷基-
苯并咪唑-2-酮衍
生物,可用作单胺神经递质再摄取
抑制剂。在其他方面,本发明披露了这些化合物在治疗方法中的应用,以及包含本发明化合物的药物组合物。